BIMEKIZUMAB DUAL INHIBITION OF IL-17A AND IL-17F PROVIDES EVIDENCE OF IL-17F CONTRIBUTION TO CHRONIC INFLAMMATION IN DISEASE-RELEVANT CELLS

被引：12

作者：

Maroof, A. ^{[1
]}

Okoye, R. ^{[1
]}

Smallie, T. ^{[1
]}

Baeten, D. ^{[2
]}

Archer, S. ^{[1
]}

Simpson, C. ^{[1
]}

Griffiths, M. ^{[1
]}

Shaw, S. ^{[1
]}

机构：

[1] UCB Pharma, Slough, Berks, England

[2] UCB Pharma, Brussels, Belgium

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷

关键词：

D O I：

10.1136/annrheumdis-2017-eular.4966

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

THU0038

引用

页码：213 / 213

页数：1

共 3 条

[1]

Expression of the T Helper 17-Associated Cytokines IL-17A and IL-17F in Asthma and COPD [J].

Doe, Camille ;

Bafadhel, Mona ;

Siddiqui, Salman ;

Desai, Dhananjay ;

Mistry, Vijay ;

Rugman, Paul ;

McCormick, Margaret ;

Woods, Joanne ;

May, Richard ;

Sleeman, Matthew A. ;

Anderson, Ian K. ;

Brightling, Christopher E. .

CHEST, 2010, 138 (05) :1140-1147

[2]

Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin [J].

Johansen, C. ;

Usher, P. A. ;

Kjellerup, R. B. ;

Lundsgaard, D. ;

Iversen, L. ;

Kragballe, K. .

BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (02) :319-324

[3]

Lima AL, 2016, BRIT J DERMATOL, V174, P514

← 1 →